Coppell Advisory Solutions Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-265	Closed	-$12.7K	–	1206
2022 Q4	$12.7K	Buy	+265	New	+$174	﹤0.01%	577

Other funds holding CLVS

RMC

Resources Management Corp West Hartford, Connecticut $794M AUM 25.46% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Coppell Advisory Solutions Corp's CLVS Position: Q1 2023 in Review

Coppell Advisory Solutions Corp sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 265 shares — an estimated $12.7K sold.

Coppell Advisory Solutions Corp first reported a position in CLVS in Q4 2022 and held it in 1 quarter. The position peaked at $12.7K in Q4 2022. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

Coppell Advisory Solutions Corp reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
Coppell Advisory Solutions Corp sold 265 Clovis Oncology, Inc. shares in Q1 2023, an estimated $12.7K.
Coppell Advisory Solutions Corp first reported a position in Clovis Oncology, Inc. in Q4 2022 and held it in 1 quarter.
Coppell Advisory Solutions Corp's Clovis Oncology, Inc. position peaked at $12.7K in Q4 2022.
2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.